Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

KRMD stock hub

KORU Medical Systems, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

192.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KRMD

In the news

Latest news · KRMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E120

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-13.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-22.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000704440
Company name	KORU Medical Systems, Inc.
Country	United States
Country code	US
Cusip	759910102
Employees	73
Employees Change	-7%
Employees Change Percent	-8.75
Enterprise value	$187.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Isin	US7599101026
Last refreshed	2026-05-10
Market cap	$192.9M
Market cap category	Micro-Cap
Price	$4.2
Price currency	USD
Rev Per Employee	592,560.48x
Sector	Healthcare
Sic	3841
Symbol	KRMD
Website	https://www.korumedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.18%
EV Sales Forward	3.79x
EV/FCF	1,045.87x
EV/Sales	4.33x
FCF yield	0.09%
Forward P/E	120x
P/B ratio	11.45x
P/S ratio	4.46x
PS Forward	3.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.99%
EBITDA Margin	-4.44%
FCF margin	0.41%
Gross margin	61.93%
Gross Profit	$26.8M
Gross Profit Growth	20.27%
Gross Profit Growth Q	19.6%
Gross Profit Growth3 Y	19.01%
Gross Profit Growth5 Y	13.25%
Net Income	$-2.3M
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	-5.22%
Profit Margin	-5.27%
Profit Per Employee	$-31,216
ROA	-5.81
Roa5y	-13.25
ROCE	-13.13
ROE	-13.7
Roe5y	-27.9
ROIC	-22.36
Roic5y	-56.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	27.85%
Cagr15y	18.72%
Cagr1y	54.46%
Cagr20y	19.46%
Cagr3y	1.56%
Cagr5y	3.25%
EPS Growth Quarters	3
EPS Growth Years	2
OCF Growth10 Y	-5.88%
Revenue Growth	23.3x
Revenue Growth Q	22.1x
Revenue Growth Quarters	9x
Revenue Growth Years	4x
Revenue Growth3 Y	14.2x
Revenue Growth5 Y	13.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.55
Assets	$28.6M
Cash	$8.8M
Current Assets	$20.6M
Current Liabilities	$8.9M
Debt	$3.4M
Debt Equity	$0.2
Debt FCF	$18.77
Equity	$16.9M
Liabilities	$11.7M
Long Term Assets	$8M
Long Term Liabilities	$2.8M
Net Cash	$5.4M
Net Cash By Market Cap	$2.8
Net Cash Growth	7.93%
Net Debt Equity	$-0.32
Net Debt FCF	$-30.13
Tangible Book Value	$16.2M
Tangible Book Value Per Share	$0.35
WACC	6.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.33
Inventory Turnover	4.25
Net Working Capital	$3.5M
Quick ratio	1.7
Working Capital	$11.7M
Working Capital Turnover	$3.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.9%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,066.67%
1Y total return	54.41%
200-day SMA	4.55
3Y total return	4.74%
50-day SMA	4.3
50-day SMA vs 200-day SMA	50under200
5Y total return	17.32%
All Time High	12.84
All Time High Change	-67.29%
All Time High Date	2020-04-22
All Time Low	0.02
All Time Low Change	27,900%
All Time Low Date	2003-02-03
ATR	0.22
Beta	0.42
Beta1y	0.88
Beta2y	1.05
Ch YTD	-27.71
High	4.39
High52	6.61
High52 Date	2025-12-24
High52ch	-36.44%
Low	4.11
Low52	2.63
Low52 Date	2025-05-23
Low52ch	60%
Ma50ch	-2.33%
Price vs 200-day SMA	-7.73%
RSI	50.51
RSI Monthly	52.64
RSI Weekly	43.86
Sharpe ratio	0.96x
Sortino ratio	1.86
Total Return	-0.9%
Tr YTD	-27.71
Tr15y	1,212.5%
Tr1m	-0.94%
Tr1w	3.19%
Tr3m	-14.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.01
Earnings Revenue Estimate	11,297,760x
Earnings Revenue Estimate Growth	17.26x
Operating Income	$-2.6M
Operating margin	-5.99
Price target	$6.5
Price Target Change	$54.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,362,633%
Float Percent	59.57%
Net Borrowing	-248,387
Shares Insiders	8.09%
Shares Institutions	39.25%
Shares Out	45,933,000
Shares Qo Q	0.08%
Shares Yo Y	0.9%
Short Float	2.69%
Short Ratio	4.74
Short Shares	1.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-2.5M
Average Volume	118,334.6x
Bv Per Share	0.37
CAPEX	$-535,242
Ch10y	1,066.7
Ch15y	1,212.5
Ch1m	-0.94
Ch1w	3.19
Ch1y	54.41
Ch20y	3,400
Ch3m	-14.63
Ch3y	4.74
Ch5y	17.32
Ch6m	7.69
Change	-5.41%
Change From Open	-3.89
Close	4.44
Days Gap	-1.58
Depreciation Amortization	672,776
Dollar Volume	616,656.6
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-2.6M
EBITDA	$-1.9M
EPS	$-0.05
F Score	3
FCF	$179,293
FCF EV Yield	0.1x
FCF Per Share	$0
Financing CF	-89,758
Fiscal Year End	December
Founded	1,980
Income Tax	$21,890
Investing CF	-592,837
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	4.76
Ma150ch	-11.73%
Ma20	4.13
Ma20ch	1.65%
Net CF	31,940
Next Earnings Date	2026-08-05
Open	4.37
Optionable	Yes
P FCF Ratio	1,076
P OCF Ratio	270
Position In Range	32.73
Post Close	4.2
Postmarket Change Percent	-0.74
Postmarket Price	$4.17
Ppne	7,193,223
Price Date	2026-05-08
Ptbv Ratio	11.9
Relative Volume	1.24x
Revenue	43,256,915x
SBC By Revenue	6.24x
Share Based Comp	2,697,459
Tax By Revenue	0.05x
Tr20y	3,400%
Tr6m	7.69%
Us State	New Jersey
Volume	146,823
Z Score	9.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRMD pay a dividend?

Capital-return profile for this ticker.

Performance

KRMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+39.2%

Float: +59.6% of shares outstanding

Insider ownership

+8.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

KRMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.5

Neutral momentum band

Price vs 200-day MA

-7.7%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current KRMD stock rating?

KORU Medical Systems, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full KRMD analysis?

The full report lives at /stocks/KRMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for KRMD?

The latest report frames KRMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the KRMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.